Cargando…

Omalizumab Restores Response to Corticosteroids in Patients with Eosinophilic Chronic Rhinosinusitis and Severe Asthma

Eosinophilic chronic rhinosinusitis (ECRS), which is a subgroup of chronic rhinosinusitis with nasal polyps, is characterized by eosinophilic airway inflammation extending across both the upper and lower airways. Some severe cases are refractory even after endoscopic sinus surgery, likely because of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kobayashi, Yoshiki, Kanda, Akira, Bui, Dan Van, Yun, Yasutaka, Nguyen, Linh Manh, Chu, Hanh Hong, Mitani, Akitoshi, Suzuki, Kensuke, Asako, Mikiya, Iwai, Hiroshi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301363/ https://www.ncbi.nlm.nih.gov/pubmed/34356851 http://dx.doi.org/10.3390/biomedicines9070787

Ejemplares similares

Reduced Local Response to Corticosteroids in Eosinophilic Chronic Rhinosinusitis with Asthma
por: Kobayashi, Yoshiki, et al.
Publicado: (2020)

CCL4 Regulates Eosinophil Activation in Eosinophilic Airway Inflammation
por: Chu, Hanh Hong, et al.
Publicado: (2022)

CCL4 Functions as a Biomarker of Type 2 Airway Inflammation
por: Kobayashi, Yoshiki, et al.
Publicado: (2022)

HFA-BDP Metered-Dose Inhaler Exhaled Through the Nose Improves Eosinophilic Chronic Rhinosinusitis With Bronchial Asthma: A Blinded, Placebo-Controlled Study
por: Kobayashi, Yoshiki, et al.
Publicado: (2018)

Eosinophilic Cholecystitis Occurred in a Patient With Refractory Eosinophilic Airway Inflammation: A Case Report
por: Kuwahara, Toshiaki, et al.
Publicado: (2019)

Efficacy of Combination Therapy with Lenvatinib and Radioactive Iodine in Thyroid Cancer Preclinical Model
por: Suzuki, Kensuke, et al.
Publicado: (2022)

A Novel Approach for Investigating Upper Airway Hyperresponsiveness Using Micro-CT in Eosinophilic Upper Airway Inflammation such as Allergic Rhinitis Model
por: Bui, Dan Van, et al.
Publicado: (2019)

Eosinophilic Upper Airway Inflammation in a Murine Model Using an Adoptive Transfer System Induces Hyposmia and Epithelial Layer Injury with Convex Lesions
por: Kanda, Akira, et al.
Publicado: (2019)

Successful management of severe asthma in a young boy with eosinophilic chronic rhinosinusitis who received omalizumab: a case report
por: Shoda, Yasuho, et al.
Publicado: (2019)

Influence of the diagnosis chronic rhinosinusitis on asthma response to omalizumab in severe, uncontrolled asthmatics
por: Sintobin, Ina, et al.
Publicado: (2015)

The clinical benefit of mepolizumab replacing omalizumab in uncontrolled severe eosinophilic asthma
por: Chapman, Kenneth R., et al.
Publicado: (2019)

Chronic rhinosinusitis with and without nasal polyps and asthma: Omalizumab improves residual anxiety but not depression
por: Vogt, Florian, et al.
Publicado: (2021)

Treatment response with mepolizumab in severe eosinophilic asthma patients with previous omalizumab treatment
por: Magnan, A., et al.
Publicado: (2016)

Update: Mepolizumab treatment in patients with severe eosinophilic asthma and prior omalizumab use
por: Albers, Frank C., et al.
Publicado: (2019)

Efficacy of mepolizumab for patients with severe asthma and eosinophilic chronic rhinosinusitis
por: Numata, Takanori, et al.
Publicado: (2019)

Regulation of Interaction Between the Upper and Lower Airways in United Airway Disease
por: Kanda, Akira, et al.
Publicado: (2019)

Serum periostin levels in asthma patients in relation to omalizumab therapy and presence of chronic rhinosinusitis with nasal polyps
por: Novosad, Jakub, et al.
Publicado: (2020)

Omalizumab and cancer risk: Current evidence in allergic asthma, chronic urticaria, and chronic rhinosinusitis with nasal polyps
por: Bagnasco, Diego, et al.
Publicado: (2022)

Effectiveness of benralizumab for allergic and eosinophilic predominant asthma following negative initial results with omalizumab
por: Minami, Daisuke, et al.
Publicado: (2018)

Clinical and economic consequences of switching from omalizumab to mepolizumab in uncontrolled severe eosinophilic asthma
por: Carpagnano, Giovanna Elisiana, et al.
Publicado: (2021)

Benefit of switching to mepolizumab from omalizumab in severe eosinophilic asthma based on patient characteristics
por: Liu, Mark C., et al.
Publicado: (2021)

Dupilumab efficacy in chronic rhinosinusitis with nasal polyps from SINUS‐52 is unaffected by eosinophilic status
por: Fujieda, Shigeharu, et al.
Publicado: (2021)

Comparison of omalizumab and mepolizumab treatment efficacy in patients with atopic and eosinophilic “Overlap” severe asthma: Biological agent preference in atopic-eosinophilic severe asthma
por: Tepetam, Fatma Merve, et al.
Publicado: (2023)

Reduction in oral corticosteroid use in patients receiving omalizumab for allergic asthma in the real-world setting
por: Braunstahl, Gert-Jan, et al.
Publicado: (2013)

Omalizumab effectiveness in patients with severe allergic asthma according to blood eosinophil count: the STELLAIR study
por: Humbert, Marc, et al.
Publicado: (2018)

A Pilot Study of Omalizumab in Eosinophilic Esophagitis
por: Loizou, Denise, et al.
Publicado: (2015)

Exacerbation of Eosinophilic Granulomatosis With Polyangiitis After Administering Dupilumab for Severe Asthma and Eosinophilic Rhinosinusitis With Nasal Polyposis
por: Tanaka, Shunya, et al.
Publicado: (2022)

Immunopathologic Role of Eosinophils in Eosinophilic Chronic Rhinosinusitis
por: Shin, Seung-Heon, et al.
Publicado: (2022)

Severe asthma and the omalizumab option
por: Miller, Christopher WT, et al.
Publicado: (2008)

Omalizumab treatment in brittle asthma
por: Skiepko, Roman, et al.
Publicado: (2014)

Efficacy of mepolizumab treatment in oral corticosteroid-dependent severe eosinophilic asthma patients with chronic rhinosinusitis with nasal polyps: single center, real life study
por: YILMAZ, İnsu, et al.
Publicado: (2020)

Omalizumab therapy in a 13-year-old boy with severe persistent asthma and concomitant eosinophilic esophagitis
por: Arasi, Stefania, et al.
Publicado: (2016)

Pathogenesis of eosinophilic chronic rhinosinusitis
por: Shah, Said Ahmad, et al.
Publicado: (2016)

Postoperative Management of Eosinophilic Chronic Rhinosinusitis with Nasal Polyps: Impact of High-Dose Corticosteroid Nasal Spray
por: Ikeda, Katsuhisa, et al.
Publicado: (2019)

Corticosteroid tapering with benralizumab treatment for eosinophilic asthma: PONENTE Trial
por: Menzies-Gow, Andrew, et al.
Publicado: (2019)

Omalizumab for Severe Asthma: Beyond Allergic Asthma
por: Loureiro, C. C., et al.
Publicado: (2018)

Comorbidity of eosinophilic chronic rhinosinusitis in chronic eosinophilic pneumonia
por: Hatsukawa, Hiroatsu, et al.
Publicado: (2023)

4-month omalizumab efficacy outcomes for severe allergic asthma: the Dutch National Omalizumab in Asthma Registry
por: Snelder, S. M., et al.
Publicado: (2017)

IL-13 Gene Polymorphisms are Associated With Rhinosinusitis and Eosinophilic Inflammation in Aspirin Intolerant Asthma
por: Palikhe, Nami Shrestha, et al.
Publicado: (2010)

Rapid Effect of Benralizumab for Hypereosinophilia in a Case of Severe Asthma with Eosinophilic Chronic Rhinosinusitis
por: Tsurumaki, Hiroaki, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_oaehlokrel71ogpg1q6b14tgde